Evidence map›Paper›PMID 41133917›Full record

ArticleAllergy2026

On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition.

Diego Alvarado, Deena M Maurer, Philip Golden, Thomas Hawthorne, Lawrence J Thomas, Margo Heath-Chiozzi, Tibor Keler, Elizabeth Crowley, Diane Young, Dorothea Terhorst-Molawi and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Diego AlvaradoCelldex Therapeutics, Hampton, New Jersey, USA.ORCID https://orcid.org/0000-0002-5878-1730
Deena M MaurerCelldex Therapeutics, Hampton, New Jersey, USA.
Philip GoldenCelldex Therapeutics, Hampton, New Jersey, USA.
Thomas HawthorneCelldex Therapeutics, Hampton, New Jersey, USA.
Lawrence J ThomasCelldex Therapeutics, Hampton, New Jersey, USA.
Margo Heath-ChiozziCelldex Therapeutics, Hampton, New Jersey, USA.
Tibor KelerCelldex Therapeutics, Hampton, New Jersey, USA.
Elizabeth CrowleyCelldex Therapeutics, Hampton, New Jersey, USA.
Diane YoungCelldex Therapeutics, Hampton, New Jersey, USA.
Dorothea Terhorst-MolawiInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.
Melba MunozInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-3386-4502
Martin MetzInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität Zu Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4070-9976

Funding

Celldex Therapeutics
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

basic mechanismsclinical immunologymast cellsurticaria

Identifiers

PMID41133917
PMCPMC12862557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.